Analytical Data
-
基因名
DPYSL5
- Application
-
别名
CRMP3-associated molecule
-
种属
Human
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BPU6
-
表达区间
1-564aa
-
分子量
66.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DPYSL5 (Down Syndrome Cell Adhesion Molecule Like 5) is a member of the DPYSL family, which is implicated in various neuronal processes, including axon guidance, neuronal differentiation, and synaptic plasticity. Dysregulation of DPYSL5 has been linked to several neurological disorders, including Down syndrome, Alzheimer's disease, and schizophrenia, highlighting its importance in maintaining normal brain function. Research on DPYSL5 recombinant proteins aims to elucidate its role in cellular signaling pathways and to better understand the molecular mechanisms underlying neuronal development and function. The production of recombinant DPYSL5 protein allows for detailed functional studies, including binding assays, cellular uptake, and interaction with other proteins involved in synaptic processes. By investigating the structure and function of DPYSL5, researchers hope to uncover potential therapeutic targets for treating neurological conditions associated with its dysregulation. Advances in this area may also contribute to the broader understanding of neural network formation and plasticity, paving the way for innovative approaches in neurobiology and therapeutic interventions.
